D-0288-2022 Class II Terminated
FDA drug recall D-0288-2022 was initiated by Denver Solutions, LLC DBA Leiters Health on Nov 29, 2021 and is designated Class II. Reason for recall: Labeling: Label Mix-up: Vials labeled as moxifloxacin 1 mg/mL may actually contain moxifloxacin 5 mg/mL The recall status is terminated (terminated Jul 12, 2022). Affected quantity: 1440 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 29, 2021
- Initiation Date
- Nov 29, 2021
- Termination Date
- Jul 12, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1440 vials
Product description
Moxifloxacin, 1 mg/mL, 1mL in 2mL vial, solution for intracameral injection, 10 vials/carton, Rx only, Leiters 13796 Compark Blvd, Englewood, CO 80112, (800) 292-6772, NDC 71449-096-42
Reason for recall
Labeling: Label Mix-up: Vials labeled as moxifloxacin 1 mg/mL may actually contain moxifloxacin 5 mg/mL
Distribution pattern
Nationwide within the United States
Code information
Lot #: 2130958; Expiration Date 03/31/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0288-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026